New probiotic passes safety check in early human trial
NCT ID NCT06380270
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 33 times
Summary
This study checked whether a specific oral probiotic (Streptococcus salivarius eK12) is safe for healthy adults to take. A total of 29 participants in Pakistan and Italy received the probiotic or a placebo. Researchers monitored for side effects and changes in vital signs, blood tests, and oral health. The goal was only to assess safety and tolerance, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOLERABILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jam Ghulam Qadir Civil Hospital
Hub, 90250, Pakistan
Conditions
Explore the condition pages connected to this study.